Stories on Pharma

Gesynta Pharma

January 22nd, 2021|

In 2020, Gesynta raised SEK 190 million in one of the year’s largest private biotech investments in the Nordic region. Now the company is one step closer to a new drug for systemic sclerosis. The future promises several innovative treatments for a number of inflammatory diseases, including cardiovascular disease and cancer.


September 28th, 2020|

BioArctic is getting closer to producing a drug that substantially limits the development of Alzheimer’s.

Cellaviva/Nextcell Pharma

September 25th, 2020|

Biobank Cellaviva offers parents-to-be the chance to store stem cells  from umbilical cord blood and tissue at birth. Experiences from stem  cell management have now led to the development of one of Sweden’s  first cell therapy drug treatments.


October 1st, 2020|

Oncopeptides has a new drug candidate for the treatment of a form of cancer of the blood, multiple myeloma, under development. KI Innovations played a key role in getting the project underway.

Modus Therapeutics

October 1st, 2020|

Many years’ research has led Mats Wahlgren to a possible first drug treatment for acute manifestations of sickle cell anemia - a genetic condition that affects millions of people.


September 25th, 2020|

The Curosurf story is a tale of success. To date, the drug has saved the lives of around one million premature babies worldwide. And the story is far from over. Despite being 73, Tore Curstedt returns to the lab every day - the lab where he has developed a new variant of a drug that is set to help many more babies in the future.